An Inquiry Has Been Opened Into Tyra Biosciences Inc’s Possible Securities Related Impropriety And Impacted Stakeholders Should Join

Rhea-AI Summary

The Schall Law Firm, a national shareholder rights litigation firm, has announced an investigation into Tyra Biosciences, Inc. (NASDAQ:TYRA) for potential violations of securities laws. The inquiry focuses on whether Tyra issued false or misleading statements or failed to disclose important information to investors. Shareholders who have suffered losses are encouraged to participate in the investigation. The firm specializes in securities class action lawsuits and shareholder rights litigation.

Interested parties can contact Brian Schall of the Schall Law Firm at 310-301-3335 or through their website www.schallfirm.com for a free consultation about their rights. The press release notes that this announcement may be considered Attorney Advertising in some jurisdictions.

Positive

• None.

Negative

• Investigation into potential securities law violations
• Possible false or misleading statements issued by the company
• Potential failure to disclose pertinent information to investors
• Risk of legal action and associated costs

LOS ANGELES, CA / ACCESSWIRE / August 27, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Tyra Biosciences, Inc. ("Tyra" or "the Company") (NASDAQ:TYRA) for violations of the securities laws.

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at bschall@schallfirm.com

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:
The Schall Law Firm
Brian Schall, Esq.
www.schallfirm.com
Office: 310-301-3335
info@schallfirm.com

SOURCE: The Schall Law Firm

View the original press release on accesswire.com

FAQ

What is the Schall Law Firm investigating regarding Tyra Biosciences (TYRA)?

The Schall Law Firm is investigating potential violations of securities laws by Tyra Biosciences (TYRA), focusing on whether the company issued false or misleading statements or failed to disclose important information to investors.

How can affected Tyra Biosciences (TYRA) shareholders participate in the investigation?

Shareholders who suffered losses can participate in the investigation by contacting Brian Schall of the Schall Law Firm at 310-301-3335 or through their website www.schallfirm.com.

What are the potential consequences for Tyra Biosciences (TYRA) if violations are found?

If violations are found, Tyra Biosciences (TYRA) could face legal action, including potential class action lawsuits, which may result in financial penalties and reputational damage.

When was the investigation into Tyra Biosciences (TYRA) announced?

The investigation into Tyra Biosciences (TYRA) was announced on August 27, 2024, according to the press release.